πŸ‡ΊπŸ‡Έ

Gilead seeks FDA approval for COVID-19 drug remdesivir

Credit: CBS News- Published on August 10, 2020
Government clearance of the emergency treatment, which will be called Veklury, would open the door to wider usage.
Advertisement

You are here


πŸ’‘ One News Page Knowledge: Other News Mentions

Food and Drug Administration

Agency of the United States Department of Health and Human Services
The new guidelines underscore the fact that a vaccine is highly unlikely before the election.
Credit: NYTimes.com - Published 1 hour ago

A drug manufacturer denounces his own industry and explains to 60 Minutes how a label change by the FDA expanded the use of opioids. Bill Whitaker reports.
Credit: CBS News - Published 1 day ago

The following is a transcript of an interview with former FDA Commissioner Scott Gottlieb that aired Sunday, September 13, 2020, on "Face the Nation."
Credit: CBS News - Published 2 days ago

The former FDA commissioner says he thinks the U.S. will have "at least one more cycle with this virus, heading into the fall and winter."
Credit: CBS News - Published 2 days ago

On this "Face the Nation" broadcast, Former President Bill Clinton and Former FDA Commissioner Scott Gottlieb sat down with Margaret Brennan
Credit: CBS News - Published 2 days ago

Related news from verified sources

Government clearance of the emergency treatment, which will be called Veklury, would open the door to wider usage.
on August 10, 2020 • CBS News

Onlookers had been expecting a thumbs up for filgotinib. Now, that won't happen for at least another year.
on August 19, 2020 • Motley Fool

Gilead's formal FDA nod of remdesivir, branded as Veklury, is likely given its conditional approval since May during the Covid pandemic. Vaxart is asking to...
on August 10, 2020 • bizjournals

You might like